SLSN

Business Context and Reporting Period

Company: Nanophase Technologies Corporation (Note: Request metadata listed "SOLESENCE, INC." but the filing text identifies the registrant as Nanophase Technologies Corporation).

Reporting Period: Quarterly period ended March 31, 2005.

Business Overview: Nanophase is a developer and commercial manufacturer of nanocrystalline materials used in personal care (sunscreens), abrasion-resistant applications, environmental catalysts, and semiconductor polishing (CMP). The company operates as a single business segment with facilities in Illinois.

Key Financial Metrics

Liquidity: Total cash, cash equivalents, and investments totaled approximately $10.2 million as of March 31, 2005.

Material Changes vs. Prior Period

• Revenue Growth: Total revenue increased 25% year-over-year, driven primarily by a 43% increase in product revenue ($1.53M vs. $1.07M). This was attributed to increased sales of sunscreen and personal care materials to BASF Corporation.
• Other Revenue Decline: Other revenue decreased 62% to $87,078, primarily due to the absence of $150,000 in technology development funding from Rohm and Haas Electronic Materials CMP, Inc. (RHEM) that was received in the prior year.
• Operating Expenses: Total operating expenses increased to $3.08M from $2.75M. Cost of revenue rose to $1.44M due to higher volume, while SG&A increased to $1.14M due to higher compensation and audit fees.
• Cash Flow: Net cash used in operating activities increased significantly to $(1.22M) from $(0.40M) in the prior year, largely due to a $353k increase in trade accounts receivable. Net cash provided by investing activities turned positive ($1.31M) due to net sales of investments, compared to a net use of $(9.63M) in the prior year.

Guidance, Outlook, and Risks

Management Commentary: Management expects revenue growth in 2005, particularly in CMP and fine polishing markets, and anticipates the launch of new sunscreen applications. The company is implementing process improvements to increase reactor output by 20-30% and reduce labor costs by 25%.

Capital Resources: The company believes current cash and investment balances are sufficient to fund operations for the foreseeable future. Capital spending for 2005 is estimated at approximately $500,000.

Material Risks and Contingencies:

• Customer Concentration: Three customers accounted for approximately 92% of revenue in Q1 2005 (87% from BASF alone). Loss of these customers would materially harm operations.
• BASF Supply Agreement Trigger: The agreement with BASF contains a "trigger" clause. If the company's earnings are negative for 12 months AND cash/investments fall below $2 million, BASF may require a technology transfer and purchase of production equipment. Management believes current cash levels avoid this trigger.
• Patent Reexamination: The USPTO granted a request for reexamination of a key patent (No. 6,669,823) regarding the NanoArc Synthesis process. A narrowing of claims could impair legal protection.
• Historical Losses: The company has an accumulated deficit of $53.6 million and expects to continue incurring losses through at least the end of 2005.

Investor Verification Checklist

• Customer Dependency: Verify the stability of the relationship with BASF, which represents the vast majority of revenue.
• Liquidity Covenants: Monitor cash and investment balances to ensure they remain above the $2 million threshold in the BASF agreement to avoid mandatory equipment sales.
• Patent Status: Track the outcome of the USPTO reexamination of Patent No. 6,669,823.
• Debt Maturity: Confirm the repayment schedule for the $460,427 promissory note held by BASF, recently extended to June 1, 2007.
• Revenue Mix: Assess the sustainability of the revenue increase from personal care products versus the decline in development funding from RHEM.